Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin degludec to insulin glargine 300 U/mL in adults with type 2 diabetes inadequately controlled on basal insulin±oral agents; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)
• insulin glargine 300 units/mL (insulin glargine)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-03-12